Home World Pfizer Inc and BioNTech SE launches clinical trial to test new version...

Pfizer Inc and BioNTech SE launches clinical trial to test new version of vaccine specifically designed to target Covid-19 Omicron variant

By
Dhrumit Thakkar
-
330
0
(G.N.S) Dt. 25 Covid-19 infection vaccine manufacturing companies-Pfizer Inc and BioNTech SE have said that a clinical trial has begun by them to test a new version of their vaccine specifically designed to target the Covid-19 Omicron variant, which has eluded some of the protection provided by the original two-dose

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   
New User Registration
*Required field

RELATED ARTICLESMORE FROM AUTHOR